In a pan-tumor meta-analysis investigating T-cell mechanisms in sensitization to checkpoint inhibitors (CPI), intra-tumoral infiltration of CD8+ CXCL13+ cells has been described as a favorable indicator of response to immunotherapy. Here, CXCL13 is linked to neoplasm.